There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19.

A series of Commonwealth and state initiatives have been enacted to ensure ongoing access to medications during the COVID-19 pandemic.

Medications may be used in conjunction with non-pharmacological treatments to manage cognition, function and behaviour in people with Alzheimer’s disease.

Evidence supports a patient-centred approach to proton pump inhibitor deprescribing involving stepping down the dose before ceasing or switching to pro re nata use.

This article reviews best practice medication management of type 2 diabetes mellitus in residential aged care facilities and highlights practical details for clinicians providing care for residents.

Australia’s new national health priority of Quality Use of Medicine and Medicine Safety should stimulate all stakeholders including consumers to work together to address off-label medicine use.

Complex regimens are challenging to administer and have been linked to non-adherence, medication errors and hospital admissions.

Medication review can be delivered using telehealth during the COVID-19 pandemic to ensure ongoing provision of care to vulnerable patient populations and to minimise risk of infection.